1,733
30
Case Study, 3 pages (650 words)

Prevention and control of diseases and health conditions

Prevention and Control of Diseases and Health Conditions Part The following table demonstrates the outcome of test: In the above table, True positive (a): Number of patients having the disease and the test is positive
False positive (b): Number of patients does not have the disease but the test is positive
True negative (d): Number of patients does not have the disease and the test is negative
False negative (c): Number of patients having the disease but the test is negative
Total test positives = a + b
Total test negatives = c + d
Total diseased = a + c
Total normal = b + d
Total population = a + b + c + d
Sensitivity = TP ÷ (TP + FN)
= 100 ÷ (100 + 850)
= 0. 10 = 10%
Specificity = TN ÷ (TN + FP)
= 2025 ÷ (2025 + 75)
= 0. 96 = 96%
Predictive Value for a + test (PPV) = TP ÷ (TP + FP)
= 100 ÷ (100 + 75)
= 0. 57 = 57%
Predictive Value for a – test (NPV) = TN ÷ (TN + FN)
= 2025 ÷ (2025 + 850)
= 0. 70 = 70%
Source: (Lalkhen & McCluskey, 2008).
Part 2
Question a
Sensitivity = a / (a + c)
= 86 / (86 + 12)
= 0. 87 = 87%
Specificity = d / (d + b)
= 352 / (352 + 25)
= 0. 93 = 93%
Positive predictive value = a / (a + b)
= 86 / (86 + 25)
= 0. 77 = 77%
Negative predictive value = d / (c + d)
= 352 / (12 + 352)
= 0. 96 = 96%
Source: (Malur et al., 2009)
Question b
Sensitivity = a / (a + c)
= 156 / (156 + 38)
= 0. 80 = 80%
Specificity = d / (d + b)
= 1150 / (1150 + 45)
= 0. 96 = 96%
Positive predictive value = a / (a + b)
= 156 / (156 + 45)
= 0. 77 = 77%
Negative predictive value = d / (c + d)
= 1150 / (38 + 1150)
= 0. 96 = 96%
Source: (Malur et al., 2009).
Question c
False positive screening test result can cause anxiety and additional expenses. Thus, the clinical and managerial impactions of false positive screening comprise new screening program which should entail explicit evaluation of the outcome of false positives. Furthermore, organizations must ensure that people establishing and operating screening programs are completely trained in every aspect of medical test.
Question d
With respect to false negative screening, organizations must ensure clinical efficiency for the medical services. The central aspect of ensuring efficiency is validity which can be measured through the level of sensitivity, specificity and predictive values.
Question e
The prevalence of disease is a vital consideration in screening activities. In this context, it can be stated that as the prevalence increases, the predictive values are affected. However, the increased prevalence of cancer has low influence on sensitivity and specificity (Petticrew et. al., 2000).
Question f
In conclusion, it can be stated that recognizing the epidemiology of transferrable diseases is vital for appropriate administration of medical care. The transferable diseases represent significant demand of screening tests which should be executed carefully in order to develop proper treatment. False screening not only results in increased anxiety, but can also give rise to delays in treatment or faults in the treatment program for patients (Fos & Fine, 2012).
References
Fos, P. J., & Fine, D. J. (2012). Managerial epidemiology for health care organizations. United States: John Wiley & Sons.
Lalkhen, A. G., & McCluskey, A. (2008). Clinical tests: sensitivity and specificity. Continuing Education in Anaesthesia, Critical Care & Pain, 8(6), 221-223.
Malur, P. R., Desai, B. R., Anita, D., Geeta, D., Bhavana, S., & Pallav, G. (2009). Sequential screening with cytology and colposcopy in detection of cervical Neoplasia. South Asian Federation of Obstetrics and Gynecology, 1(3), 45-48.
Petticrew, M. P., Sowden, A. J., Lister-Sharp, D., Wright, K. (2000). False-negative results in screening programmes: systematic review of impact and implications. Health Technology Assessment, 4(5), 1-70.

Thank's for Your Vote!
Prevention and control of diseases and health conditions. Page 1
Prevention and control of diseases and health conditions. Page 2
Prevention and control of diseases and health conditions. Page 3
Prevention and control of diseases and health conditions. Page 4
Prevention and control of diseases and health conditions. Page 5

This work, titled "Prevention and control of diseases and health conditions" was written and willingly shared by a fellow student. This sample can be utilized as a research and reference resource to aid in the writing of your own work. Any use of the work that does not include an appropriate citation is banned.

If you are the owner of this work and don’t want it to be published on AssignBuster, request its removal.

Request Removal
Cite this Case Study

References

AssignBuster. (2022) 'Prevention and control of diseases and health conditions'. 2 October.

Reference

AssignBuster. (2022, October 2). Prevention and control of diseases and health conditions. Retrieved from https://assignbuster.com/prevention-and-control-of-diseases-and-health-conditions-case-study-samples/

References

AssignBuster. 2022. "Prevention and control of diseases and health conditions." October 2, 2022. https://assignbuster.com/prevention-and-control-of-diseases-and-health-conditions-case-study-samples/.

1. AssignBuster. "Prevention and control of diseases and health conditions." October 2, 2022. https://assignbuster.com/prevention-and-control-of-diseases-and-health-conditions-case-study-samples/.


Bibliography


AssignBuster. "Prevention and control of diseases and health conditions." October 2, 2022. https://assignbuster.com/prevention-and-control-of-diseases-and-health-conditions-case-study-samples/.

Work Cited

"Prevention and control of diseases and health conditions." AssignBuster, 2 Oct. 2022, assignbuster.com/prevention-and-control-of-diseases-and-health-conditions-case-study-samples/.

Get in Touch

Please, let us know if you have any ideas on improving Prevention and control of diseases and health conditions, or our service. We will be happy to hear what you think: [email protected]